Member Info for EarlofAim

OK not getting 10 bagger today, buy my word, Collaborations with Johnson & Johnson pharmaceutical (Janssen)
and the findings is awesome!!

" The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling"

is there any better opportunity than Midatech on AIM right now?
MTPH Cash £10M

Mcap £13M

MTPH Cash £10M

Mcap £13M

listen from 17 min 30 sec onwards for financial summary.
of course Worth a careful listen to the whole of the video to grasp the enormity of Midatech Pharma

https://youtu.be/SgE_7nex6Yk

MTPH Cash £10M

Mcap £13M

listen from 17 min 30 sec onwards is for financial summary.
of course Worth a careful listen to the whole of the video to grasp the enormity of Midatech Pharma

https://youtu.be/SgE_7nex6Yk

as per Rns on 9th March Janssen (Johnson & Johnson pharmaceutical company) collaboration looking good.

The most exciting play on AIM goes to this £13M Mcap company with £10m cash is @Midatech and MTPH

Huge commercial deal coming

The most exciting play on AIM goes to this £13M Mcap company with £10m cash is @Midatech and MTPH

Huge commercial deal coming

had a I known the basic metrics to do calculations I would have done it, however with Pharmaceutical companies it's about how big the drug market is, for MTPH it's about how effective the drug delivery system is.

I would say on deal news MTPH could do 20 Bagger because of the low Mcap of £13M
******£260M is 20 Bagger ******

someone loading up

not suprise,
Undervalued and under the radar company.

cashed up £10M, and Mcap £13M

taken from Rns 9 March

someone knows what's coming

looks like many missed this rns
"The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling."

massive collaboration with one of the leading companies in the industry!!

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson,

Ltel

nice summary on the Board of directors.

I agree 100% 2012 directors no morals

Comon who dodge this bullet today,

was very risky to hold At £270M Mcap on no revenue producing.
Crazy crazy.

look at MTPH, news of hundreds of million dollars deal coming.

is this the first time this happened?

no no no
yet people blame 88E, DON'T BLAME 88E, BLAME YOURSELF.

last time it tanked 80% 2012,
still long way for the drop.

I don't understand why this isn't 96% down, look at the ridiculous Mcap.
it's unbelievable this company has Mcap over £20M

max should be £20M and not bloddy £160M

feel sorry for the newbies

taken from Rns 9 March

someone knows what's coming

looks like many missed this rns
"The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling."

massive collaboration with one of the leading companies in the industry!!

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson,

someone knows what's coming

looks like many missed this rns
"The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling."

massive collaboration with one of the leading companies in the industry!!

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson,

massive collaboration with one of the leading companies in the industry!!

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson,

get ready for commercial scaling...

looks like many missed this rns
"The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling."

Midatech Pharma PLC (AIM: MTPH; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce an extension of its existing R&D collaboration with Janssen Pharmaceutica NV (Janssen) originally announced on 21 July 2020.

On 17 June 2021 the Company announced that, using its Q-Sphera technology, it had successfully encapsulated a proprietary Janssen experimental large molecule medicine and importantly preserved its functional integrity. The Company believes no other commercial or academic organisation has been able to successfully deliver any such experimental medicine over extended periods using methods capable of commercial scaling.

£10M/$13m cash
Mcap £13M
#MTPH
$MTP
NASDAQ listed

Fantastic presentation 2 months ago news due anyday

17min 30 sec onwards ($13M cash said CEO)

Fantastic pipeline

https://t.co/boi7xwwMEN

$MTP
#NASDAQ listed

Fantastic presentation 2 months ago news due anyday

17min 30 sec onwards ($13M cash said CEO)

Fantastic pipeline

#Val #nnn #dddd #OCTP #dnl #Mhc #odx #avct #gdr #brh #NCYT #SNG #HEMO #CIZ #IMM

https://t.co/boi7xwwMEN

Friday Post Market Nasdaq up 8%

not all placing are bad

Jay had placing on 24 March yesterday at 7p, its trading at 10p

30% rise.

why Mobile can't rise 100% from here is unbelievable.
it can in fact rise 200% in the next few months depending on the RNS's.
GL